2022
Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders
Wilbourn B, Ogburn DF, Safon CB, Galvao RW, Kershaw TS, Willie TC, Taggart T, Caldwell A, Kaplan C, Phillips N, Calabrese SK. Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders. Health Promotion Practice 2022, 24: 764-775. PMID: 35414273, PMCID: PMC9589894, DOI: 10.1177/15248399221086616.Peer-Reviewed Original ResearchConceptsPrEP implementationInner settingClinical care team membersReproductive health care settingsDelivery of PrEPReproductive health settingsHIV prevention servicesPatient-provider communicationCare team membersReproductive health careHealth care settingsProphylaxis implementationPreexposure prophylaxisPrEP knowledgePatient levelCare settingsPrevention servicesHealth settingsConsolidated FrameworkPrEP trainingPrEPHealth careImplementation researchOptimal venueCisgender women
2020
Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices
Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, Caldwell A, Blackstock O, Phillips NJ, Kershaw TS. Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices. AIDS Patient Care And STDs 2020, 34: 132-146. PMID: 32202930, PMCID: PMC7087409, DOI: 10.1089/apc.2019.0242.Peer-Reviewed Original ResearchConceptsPrEP modalitiesDaily pillContraception practicesHIV pre-exposure prophylaxisPre-exposure prophylaxisLow uptakePlanned Parenthood centersWomen ages 18Non-Hispanic blacksWomen's preferencesExposure prophylaxisPrEP acceptabilityPrEP uptakeHIV incidenceBirth control practicesActive womenVaginal ringHigher oddsCommon reasonSexual healthReproductive healthSociodemographic characteristicsAge 18WomenPills
2019
Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, Blackstock O, Taggart T, Kaplan C, Caldwell A, Kershaw TS. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 81: 395-405. PMID: 30973543, PMCID: PMC6594908, DOI: 10.1097/qai.0000000000002042.Peer-Reviewed Original ResearchMeSH KeywordsAnti-HIV AgentsFemaleGuidelines as TopicHealth Knowledge, Attitudes, PracticeHIV InfectionsHIV SeropositivityHumansMaleMotivationPatient Acceptance of Health CarePre-Exposure ProphylaxisRisk FactorsRisk-TakingSexual PartnersSexually Transmitted DiseasesSurveys and QuestionnairesUnited StatesConceptsHIV pre-exposure prophylaxisPrEP eligibilityPre-exposure prophylaxisIndication criteriaPrEP accessHIV riskWomen's knowledgeDisease controlHigh self-perceived riskHIV-risk indicatorsPrevention clinical guidelinesHIV-negative womenCurrent US guidelinesSelf-perceived riskPlanned Parenthood centersMultiple sex partnersNon-Hispanic whitesPartners' HIV riskVersion of CentersPrEP useHIV protectionOwn risk behaviorsClinical guidelinesPrevention criteriaCurrent guidelines